JPWO2022038261A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022038261A5 JPWO2022038261A5 JP2023512647A JP2023512647A JPWO2022038261A5 JP WO2022038261 A5 JPWO2022038261 A5 JP WO2022038261A5 JP 2023512647 A JP2023512647 A JP 2023512647A JP 2023512647 A JP2023512647 A JP 2023512647A JP WO2022038261 A5 JPWO2022038261 A5 JP WO2022038261A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutical composition
- administered
- composition according
- dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20382764.7 | 2020-08-21 | ||
| EP20382764.7A EP3957308A1 (en) | 2020-08-21 | 2020-08-21 | (1r,3s)-3-((5-cyano-4-phenylthiazol-2-yl)carbamoyl)cyclopentane-1-carboxylic acid and derivatives thereof for use in the treatment of airway diseases |
| PCT/EP2021/073133 WO2022038261A1 (en) | 2020-08-21 | 2021-08-20 | (1r,3s)-3-((5-cyano-4-phenylthiazol-2-yl)carbamoyl)cyclopentane-1-carboxylic acid and derivatives thereof for use in the treatment of airway diseases |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023538419A JP2023538419A (ja) | 2023-09-07 |
| JPWO2022038261A5 true JPWO2022038261A5 (https=) | 2024-07-29 |
| JP2023538419A5 JP2023538419A5 (https=) | 2024-07-29 |
| JP7794807B2 JP7794807B2 (ja) | 2026-01-06 |
Family
ID=72234795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023512647A Active JP7794807B2 (ja) | 2020-08-21 | 2021-08-20 | 気道疾患の治療に使用するための（１ｒ，３ｓ）－３－（（５－シアノ－４－フェニルチアゾール－２－イル）カルバモイル）シクロペンタン－１－カルボン酸およびその誘導体 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20230321053A1 (https=) |
| EP (2) | EP3957308A1 (https=) |
| JP (1) | JP7794807B2 (https=) |
| KR (1) | KR20230054444A (https=) |
| CN (1) | CN115942933A (https=) |
| AU (1) | AU2021327728A1 (https=) |
| BR (1) | BR112023002778A2 (https=) |
| CA (1) | CA3190081A1 (https=) |
| DK (1) | DK4199922T3 (https=) |
| ES (1) | ES3001104T3 (https=) |
| FI (1) | FI4199922T3 (https=) |
| HR (1) | HRP20241621T1 (https=) |
| HU (1) | HUE069338T2 (https=) |
| LT (1) | LT4199922T (https=) |
| MX (1) | MX2023002156A (https=) |
| PL (1) | PL4199922T3 (https=) |
| PT (1) | PT4199922T (https=) |
| RS (1) | RS66263B1 (https=) |
| SI (1) | SI4199922T1 (https=) |
| WO (1) | WO2022038261A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102460040B1 (ko) | 2016-04-27 | 2022-11-01 | 애브비 인코포레이티드 | 항-il-13 항체를 이용한 il-13 활성이 유해한 질환의 치료 방법 |
| US12162940B2 (en) | 2021-05-05 | 2024-12-10 | Immatics Biotechnologies Gmbh | BMA031 antigen binding polypeptides |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070219223A1 (en) | 2006-03-07 | 2007-09-20 | Endacea, Inc. | Compositions and methods for treating respiratory disorders |
| ES2331220B1 (es) | 2007-10-02 | 2010-09-23 | Palobiofarma, S.L. | Nuevos compuestos como antagonistas de los receptores a1 de adenosina. |
| KR20160061352A (ko) | 2013-10-15 | 2016-05-31 | 메디뮨 엘엘씨 | 벤랄리주맙을 사용하여 만성 폐쇄성 폐 질환을 치료하는 방법 |
| UA122670C2 (uk) * | 2014-09-08 | 2020-12-28 | Сефалон, Інк. | Спосіб лікування еозинофільної астми у пацієнта |
| ES2676535B1 (es) * | 2017-01-20 | 2019-04-29 | Palobiofarma Sl | Moduladores de los receptores a3 de adenosina |
| LT3592734T (lt) | 2017-03-06 | 2021-07-26 | Palobiofarma, S.L. | (1r,3s)-3-(5-ciano-4-fenil-1,3-tiazol-2-ilkarbamoil)ciklopentankarboksirūgšties amino druska |
-
2020
- 2020-08-21 EP EP20382764.7A patent/EP3957308A1/en not_active Withdrawn
-
2021
- 2021-08-20 RS RS20241285A patent/RS66263B1/sr unknown
- 2021-08-20 CA CA3190081A patent/CA3190081A1/en active Pending
- 2021-08-20 MX MX2023002156A patent/MX2023002156A/es unknown
- 2021-08-20 PL PL21765908.5T patent/PL4199922T3/pl unknown
- 2021-08-20 HU HUE21765908A patent/HUE069338T2/hu unknown
- 2021-08-20 FI FIEP21765908.5T patent/FI4199922T3/fi active
- 2021-08-20 DK DK21765908.5T patent/DK4199922T3/da active
- 2021-08-20 AU AU2021327728A patent/AU2021327728A1/en active Pending
- 2021-08-20 KR KR1020237009717A patent/KR20230054444A/ko active Pending
- 2021-08-20 CN CN202180051106.2A patent/CN115942933A/zh active Pending
- 2021-08-20 HR HRP20241621TT patent/HRP20241621T1/hr unknown
- 2021-08-20 LT LTEPPCT/EP2021/073133T patent/LT4199922T/lt unknown
- 2021-08-20 US US18/040,508 patent/US20230321053A1/en active Pending
- 2021-08-20 WO PCT/EP2021/073133 patent/WO2022038261A1/en not_active Ceased
- 2021-08-20 BR BR112023002778A patent/BR112023002778A2/pt unknown
- 2021-08-20 PT PT217659085T patent/PT4199922T/pt unknown
- 2021-08-20 EP EP21765908.5A patent/EP4199922B1/en active Active
- 2021-08-20 ES ES21765908T patent/ES3001104T3/es active Active
- 2021-08-20 JP JP2023512647A patent/JP7794807B2/ja active Active
- 2021-08-20 SI SI202130242T patent/SI4199922T1/sl unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7238661B2 (en) | Oral lactoferrin in the treatment of respiratory disorders | |
| KR20140012989A (ko) | 글리코피롤레이트 및 베타2-효능제의 조합 | |
| JP2008031184A (ja) | 気道流路および肺疾患の処置のためのモメタゾンフロエートの使用 | |
| AU2020226339B2 (en) | Methods of treatment of respiratory disorders | |
| AU2008241045B2 (en) | Use of a composition comprising formoterol and beclometasone dipropionate for the prevention and/or treatment of an exacerbation of asthma | |
| FI4199922T3 (fi) | (1r,3s)-3-((5-syano-4-fenyylitiatsol-2-yyli)karbamoyyli)syklopentaani-1-karboksyylihappo käytettäväksi hengitystietautien hoidossa | |
| JPWO2022038261A5 (https=) | ||
| JP5068912B2 (ja) | ロテプレドノールとβ２アドレナリン受容体アゴニストの新規組み合わせ | |
| CN1306429A (zh) | 糖皮质类固醇在制备治疗轻度/早期c opd(慢性阻塞性肺病)的药物中的应用 | |
| US20190224164A1 (en) | Compositions and methods for treatment of copd | |
| JP6021952B2 (ja) | 慢性閉塞性肺疾患の治療法 | |
| JP2016504358A (ja) | オキシブチニンを投与するための方法および組成物 | |
| JPWO2022031956A5 (https=) | ||
| JP5220741B2 (ja) | アンドラスト／グルココルチコイドの併用 | |
| JPWO2023097276A5 (https=) | ||
| NZ707754B2 (en) | Combination of glycopyrrolate and a beta2 -agonist | |
| JP2013056925A (ja) | アンドラスト／グルココルチコイドの併用 | |
| HK1137357B (en) | Use of a composition comprising formoterol and beclometasone dipropionate in the manufacture of a pharmaceutical for the prevention and/or treatment of an exacerbation of asthma |